$NI Balance Sheet | Understand Stock

$NI

$43.44 +$0.16 (0.37%) Close

$NI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Property, Plant and Equipment
Plant
Accumulated depreciation and amortization
Net Property, Plant and Equipment
us-gaap_VariableInterestEntityPrimaryBeneficiaryMemberGenCo
Joint Ventures
Total net Property, Plant and Equipment
Investments and Other Assets
Unconsolidated affiliates
Available-for-sale debt securities (amortized cost of $164.6 and $145.8, respectively)
Other investments
Total Investments and Other Assets
Current Assets
Cash and cash equivalents
Restricted Cash
Accounts receivable
Allowance for credit losses
Accounts receivable, net
Gas storage
Materials and supplies, at average cost
Electric production fuel, at average cost
Exchange gas receivable
Regulatory assets
Deferred property taxes
Income Taxes Receivable
Prepayments and other
us-gaap_VariableInterestEntityPrimaryBeneficiaryMemberGenCo
Joint Ventures
Total Current Assets

Other Assets
Regulatory assets
Goodwill
Deferred charges and other
Total Other Assets
us-gaap_VariableInterestEntityPrimaryBeneficiaryMemberGenCo
Total Assets
CAPITALIZATION AND LIABILITIES
Capitalization
Stockholders' Equity
Common stock - $0.01 par value,750,000,000 shares authorized; 479,498,053 and 478,432,058 shares outstanding, respectively
Preferred Stock, Shares Outstanding
Preferred stock - par value, 20,000,000 shares authorized; 0 and 0 shares outstanding, respectively
Treasury stock
Additional paid-in capital
Retained deficit
Accumulated other comprehensive loss
Total NiSource Stockholders’ Equity
Noncontrolling interest in consolidated subsidiaries
Total Stockholders’ Equity
Long-term debt, excluding amounts due within one year
Total Capitalization
Current Liabilities
Current portion of long-term debt
Short-term borrowings
Accounts payable
Dividends payable - common stock
Dividends payable - preferred stock
Customer deposits and credits
Taxes accrued
Interest accrued
Asset retirement obligations
Exchange gas payable
Regulatory liabilities
Asset Retirement Obligation
Accrued compensation and employee benefits
Obligations to renewable generation asset developer
Other accruals
us-gaap_VariableInterestEntityPrimaryBeneficiaryMemberGenCo
Joint Ventures
Total Current Liabilities
Other Liabilities
Deferred income taxes
Accrued liability for postretirement and postemployment benefits
Regulatory liabilities
Asset retirement obligations
Other noncurrent liabilities
Joint Ventures
Total Other Liabilities
Total Capitalization and Liabilities
Common Stock, Par or Stated Value Per Share
Common Stock, Shares Authorized
Common Stock, No Par Value
Deposits to renewable generation asset developer
Prepaid Expense, Current
Other Assets
us-gaap_VariableInterestEntityPrimaryBeneficiaryMemberGenCo
Variable Interest Entity Primary Beneficiary Member GenCo
Accrued insurance liabilities

Comments